Clinical Trials
32 trialsNCT07020754 2026-01-30
Effect of Arginine- and Glutamine-based Oral Formulations on Salivary Biomarkers and Clinical Severity of Radiation-induced Oral Mucositis in Head and Neck Cancer: A Randomized Controlled Trial
Ain Shams University
Phase 2 Completed
NCT03515538 2024-11-04
PREVLAR
EpicentRx, Inc.
Phase 2 Completed
NCT05918224 2024-02-05
Streptococcus Salivarius K12 for Prevention and Treatment of Oral Mucositis in Patients Undergoing Radiotherapy
West China Hospital
Phase 2 Completed
NCT03200340 2023-07-27
EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation
Enzychem Lifesciences Corporation
Phase 2 Completed
NCT03469284 2023-04-25
MOM's PAIN (Methylene Blue for Oral Mucositis' PAIN)
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02229136 2022-12-01
Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus
US Oncology Research
Phase 2 Completed
NCT04529850 2022-08-16
Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck Cancer
Galera Therapeutics, Inc.
Phase 2 Completed
NCT02399228 2021-11-19
A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of Oral Mucositis
Santalis Pharmaceuticals, Inc.
Phase 2 Completed
NCT05101889 2021-11-01
Benefits of Immunonutrition in Patients With Head and Neck Cancer Receiving Chemoradiation
Prince of Songkla University
Phase 2 Completed
NCT02508389 2021-09-20
A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer
Galera Therapeutics, Inc.
Phase 2 Completed
NCT02807337 2020-02-20
Supersaturated Calcium Phosphate Oral Rinse (Caphosol®) For the Prevention of Oral Mucositis in Children Undergoing Chemotherapeutic Treatments
Tampere University Hospital
Phase 2 Completed
NCT02324335 2019-01-16
Brilacidin
Innovation Pharmaceuticals, Inc.
Phase 2 Completed
NCT02885376 2018-12-21
Study of Dentoxol® Mouthrinse for Oral Mucositis
Ingalfarma SpA
Phase 2 Completed
NCT01941992 2018-09-13
ROSAM
Istituto Oncologico Veneto IRCCS
Phase 2 Completed
NCT03577535 2018-08-01
Evaluation of ONCOXIN® in Oral Mucositis, Appetite and Body Mass in Cancer Patients.
Catalysis SL
Phase 2 Completed
NCT01400620 2018-03-13
Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer
Izun Pharma Ltd
Phase 2 Completed
NCT01385748 2017-11-28
Efficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis
Valerio Therapeutics
Phase 2 Completed
NCT03348241 2017-11-20
Using Gum Arabic for Cancer Patients to Protect From Oral Mucositis Caused by Chemotherapy: ِِِAn Experimental Study
University of Science and Technology, Yemen
Phase 2 Completed
NCT02013050 2017-08-28
A Dose Escalating Study of SGX942 for Oral Mucositis in Patients With Head and Neck Cancer
Soligenix
Phase 2 Completed
NCT01898091 2017-03-06
OM
Medical University of South Carolina
Phase 2 Completed
NCT00323518 2016-04-13
A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
Celldex Therapeutics
Phase 2 Completed
NCT00104065 2016-03-15
Safety and Efficacy of CG53135-05 in the Prevention of Oral Mucositis in Patients Receiving Bone Marrow Transplant
Celldex Therapeutics
Phase 2 Completed
NCT00845819 2015-01-21
EGFOM
Seoul National University Hospital
Phase 2 Completed
NCT00189488 2014-09-15
Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation
Swedish Orphan Biovitrum
Phase 2 Completed
NCT00698204 2014-06-05
Cox-2 Inhibition in Radiation-induced Oral Mucositis
UConn Health
Phase 2 Completed
NCT00267046 2012-05-16
Evaluate PKs and Efficacy Assessment of Palifermin in Patients With Sarcoma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00965172 2012-03-22
Caphosol in Sarcoma Patients With Mucositis
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01083875 2010-03-18
Study to Determine the Effects Treatment With Amlexanox 0.5% Oral Rinse Solution on Oral Mucositis Associated With Radiation Therapy for Cancer of the Head and Neck Region
Access Pharmaceuticals, Inc.
Phase 2 Completed
NCT00756951 2009-11-23
SCV-07 OM
SciClone Pharmaceuticals
Phase 2 Completed
NCT00385515 2009-05-07
Efficacy of SNX-1012 in the Treatment of Oral Mucositis
Mucosal Therapeutics
Phase 2 Completed
NCT00289003 2007-01-17
The Protective Effect of Soluble Beta-1,3/1,6-Glucan Compared to Placebo in Oral Mucositis in Head and Neck Cancer Patients
Biotec Pharmacon ASA
Phase 2 Completed
NCT00230191 2007-01-15
Safety and Efficacy of RK0202 in Oral Mucositis
RxKinetix
Phase 2 Completed